Home > News & Media > Quest Diagnostics News

Quest Diagnostics News

Quest Diagnostics News Feed

OVA1 Blood Test Now Available to Aid Pre-surgical Evaluation of Women for Ovarian Cancer 03-09-2010

FDA-cleared test helps direct women to the most appropriate surgeon, promoting better outcomes

Read More

Quest Diagnostics Ranked Among FORTUNE Magazine's 'World's Most Admired Companies' For Third Consecutive Year 03-05-2010

Company also ranked among top 100 Best Corporate Citizens by Corporate Responsibility Magazine

Read More

Quest Diagnostics and Surescripts to Pioneer Integrated Service Combining Lab and Prescription Information to Improve Patient Safety and Clinical Outcomes 03-04-2010

Read More

Quest Diagnostics to Speak at the RBC Capital Markets 2010 Healthcare Conference 03-01-2010

Read More

Quest Diagnostics Unveils Care360™ EHR 03-01-2010

Company Empowers Physicians to Embrace Digital Healthcare, Connect with Peers, and Work Toward Meaningful Use One Step at a Time

Read More

Quest Diagnostics Declares Quarterly Cash Dividend 02-11-2010

Read More

Quest Diagnostics to Speak at the UBS Global Healthcare Services Conference 02-05-2010

Read More

Quest Diagnostics Reports Strong Performance for Fourth Quarter and Full Year 2009; Provides Guidance for 2010 01-25-2010

- Fourth quarter diluted EPS grew 11% on revenue growth of 2.7%; cash from operations totaled $360 million

Read More

Quest Diagnostics Increases Share Repurchase Authority By $750 Million 01-25-2010

Read More

Quest Diagnostics To Speak at the Jefferies 2010 Global Healthcare Services Conference 01-19-2010

Read More

Quest Diagnostics News

H1N1. What You Should Know.

Learn about testing options for 2009 H1N1 Influenza Virus Testing (... Read full article

Quest Diagnostics News

Is Drug Use Costing Your Company?

Use our Drug Testing Return on Investment Calculator to... Read full article

Quest Diagnostics News

Quest Diagnostics Reports Strong Performance in Third Quarter 2009

Kansas City, MO - 2009

- Total revenues of $1.9 billion, up 3.9%
- Diluted earnings of $1.02 per share, up 26%
- Cash flow from operations of $374 million, up 14%
- 2009 EPS outlook increased to a... Read full article

Contact Us

For more information about out products and services, or to find address, phone or email information, click here.

Lab Image Gallery

 

Is Drug Use Costing Your Company?

Use our Drug Testing Return on Investment Calculator to learn how much money your company can save with a drug testing program through Quest Diagnostics.